Repeat-Dose Toxicity Study of a Lyophilized Recombinant Protective Antigen-Based Anthrax Vaccine Adjuvanted With CpG 7909

Vladimir Savransky,Michael J. Lacy,Boris Ionin,Mario H. Skiadopoulos,Jeffry D. Shearer

Repeat-Dose Toxicity Study of a Lyophilized Recombinant Protective Antigen-Based Anthrax Vaccine Adjuvanted With CpG 7909

2019

Vladimir Savransky
Michael J. Lacy
Boris Ionin
Mario H. Skiadopoulos
Jeffry D. Shearer

A recombinant protective antigen (rPA) anthrax vaccine candidate (rPA7909) was developed as a next-generation vaccine indicated for postexposure prophylaxis of disease resulting from suspected or c...

Keywords:

Anthrax vaccines
Biochemistry
Virology
Protective antigen
Biology
CpG site
Recombinant DNA
REPEAT DOSE TOXICITY

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations